Literature DB >> 7720463

Preduodenal mechanisms compensate completely for absent pancreatic enzymes to stimulate gallbladder after meals.

J H Meyer1, M Hlinka, D Jehn, Y G Gu.   

Abstract

We studied gallbladder emptying with gamma scintigraphy in nine dogs prepared with chronic pancreatic fistulas, so that pancreatic enzymes could be either completely excluded from the duodenum or supplied in normal amounts. During duodenal perfusion of the fasted dogs with fat emulsions, gallbladder emptying was significantly less rapid when the emulsion contained inactive vs active enzymes, confirming the potency of lipolytic products in the intestine as stimuli of gallbladder emptying. However, after feeding either a 115-g or a 460-g meal, each 18% fat, the gallbladders emptied identically whether or not pancreatic enzymes were excluded from the duodenum. We concluded that while products of pancreatic lipolysis in the small intestine are potent stimuli of gallbladder contraction, preduodenal mechanisms can compensate completely for the absence of pancreatic hydrolysis in stimulating gallbladder emptying after a meal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720463     DOI: 10.1007/bf02064971

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Evidence for a pyloro-cholecystic reflex for gallbladder contraction.

Authors:  H T Debas; T Yamagishi
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

2.  Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo.

Authors:  T Takahashi; D May; C Owyang
Journal:  Am J Physiol       Date:  1991-10

3.  Error and corrections with scintigraphic measurement of gastric emptying of solid foods.

Authors:  J H Meyer; G VanDeventer; L S Graham; J Thomson; D Thomasson
Journal:  J Nucl Med       Date:  1983-03       Impact factor: 10.057

4.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Factors that affect the performance of lipase on fat digestion and absorption in a canine model of pancreatic insufficiency.

Authors:  J H Meyer; Y G Gu; D Jehn; J E Doty
Journal:  Pancreas       Date:  1994-09       Impact factor: 3.327

6.  Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment.

Authors:  P T Regan; J R Malagelada; E P Dimagno; V L Go
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

7.  Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay.

Authors:  S Himeno; S Tarui; S Kanayama; T Kuroshima; Y Shinomura; C Hayashi; K Tateishi; K Imagawa; E Hashimura; T Hamaoka
Journal:  Am J Gastroenterol       Date:  1983-11       Impact factor: 10.864

8.  Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.

Authors:  B Borgström
Journal:  Biochim Biophys Acta       Date:  1988-10-14

9.  Effect of replenished lipase on postcibal absorption of fat in a canine model of pancreatic insufficiency.

Authors:  J H Meyer; Y G Gu; J E Doty
Journal:  Pancreas       Date:  1994-07       Impact factor: 3.327

10.  Inactivation of pancreatic and gastric lipases by THL and C12:0-TNB: a kinetic study with emulsified tributyrin.

Authors:  Y Gargouri; H Chahinian; H Moreau; S Ransac; R Verger
Journal:  Biochim Biophys Acta       Date:  1991-10-01
View more
  1 in total

1.  Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.

Authors:  F Froehlich; D Hartmann; C Guezelhan; J J Gonvers; J B Jansen; M Fried
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.